Benztropine

Overview

Benztropine (Benzatropine; Benzotropine) is an orally active and BBB-permeable centrally acting anticholinergic agent that can be used for Parkinson's disease research . Benztropine is an anti-histamine agent and a dopamine re-uptake inhibitor. Benztropine is also a human D 2 dopamine receptor allosteric antagonist. Benztropine mesylate also has anti-CSCs ( cancer stem cells ) effects.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Dopamine Receptor | Products > Signaling Pathways > mAChR | Products > Signaling Pathways > Histamine Receptor

Product Information

• Catalog No.: HY-B0520
• CAS No.: 86-13-5
• Molecular Formula: C21H25NO
• Molecular Weight: 307.43
• Purity: 98.12%
• Storage: Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (8.13 mM); Clear solution
• Availability: In-stock

Source

Original product source